The Sensitivity of Natural Killer Cells to Psychological Stress and Implications for Cancer

AI–Assisted Overview Article

BrainImmune’s aim is to narrow the informational and conceptual gap at the interface of neurosciences and immunology. We believe that the neuroendocrine-immune dysfunction and abnormal stress-immune interactions represent major components essential to all common complex human diseases.

BrainImmune features over 100 articles in this area, with more than 25 articles related to stress and cancer. Given the important role of stress in the development of cancer, we and others have raised the special case of natural killer (NK) cells.

It appears that NK cells are the most ‘sensitive’ cells to the suppressive effect of stress. In the past, NK cell activity has been used as a genuine index of stress-induced suppression of cellular immunity. Overall, the NK cells’ ‘supersensitivity’ to the effects of stress is perhaps a major factor contributing to the suppression of cellular immunity and perhaps its complete failure in cancer.

We decided to use an Artificial Intelligence (AI) to find out the answer for two critical questions:

1. What are the potential mechanisms driving the apparent heightened sensitivity of NK cells to the effects of psychological stress?
2. What are the implications of stress-induced alterations in NK cell function for cancer initiation, progression, and metastasis?

Please find the answers below.

I. Introduction

A. Natural Killer (NK) Cells: Key Effectors of Innate Immunity

Natural Killer (NK) cells represent a distinct lineage of lymphocytes, separate from T and B cells, that constitute a critical component of the innate immune system.¹ First identified in the 1970s, their name derives from their intrinsic ability to recognize and eliminate target cells, such as those infected with viruses or undergoing malignant transformation, without the need for prior sensitization or antigen-specific priming.² Morphologically, they are often characterized as large granular lymphocytes (LGLs) due to their size and the presence of cytoplasmic granules containing cytotoxic effector molecules like perforin and granzymes.²

Human natural killer cell, colorized scanning electron micrograph, Wikipedia.

These cells play a pivotal role in immune surveillance, constantly monitoring the body for unhealthy cells.¹ Their functions extend beyond direct cytotoxicity; they are also significant producers of cytokines, such as interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α), which modulate the activity of other immune cells, bridging the innate and adaptive immune responses.³ NK cells recognize target cells through a complex interplay of activating and inhibitory receptors expressed on their surface.¹ Activating receptors bind to ligands often upregulated on stressed, infected, or transformed cells, while inhibitory receptors typically recognize self-Major Histocompatibility Complex (MHC) class I molecules, preventing attacks on healthy host cells – a concept known as the “missing-self” hypothesis.²

Human NK cells are not a homogenous population but comprise distinct subsets with differing functional capacities and tissue distributions.⁴ The two major subsets in peripheral blood are distinguished by the surface expression density of CD56 and the presence of CD16 (FcγRIII).² CD56^dimCD16⁺ NK cells constitute the majority (~90%) in blood, are highly cytotoxic, mediate antibody-dependent cellular cytotoxicity (ADCC), and produce relatively lower levels of cytokines upon stimulation.³ Conversely, CD56^brightCD16^– NK cells are less abundant in blood (~10%) but predominate in secondary lymphoid tissues and the uterine decidua.¹⁰ These cells are characterized by potent cytokine production (especially IFN-γ) in response to monokines like IL-12 and IL-15, possess lower baseline cytotoxicity (though this can be enhanced by cytokine activation), and exhibit higher proliferative capacity.³

B. Psychological Stress and the Neuroendocrine-Immune Axis

Psychological stress arises when an organism perceives environmental or internal demands as exceeding its ability to cope, triggering a cascade of physiological and behavioral responses designed to restore homeostasis.³⁸ The field of psychoneuroimmunology (PNI) investigates the intricate, bidirectional communication pathways linking the central nervous system (CNS), the endocrine system, and the immune system.³⁸ This communication network allows psychological events perceived by the brain to influence immune function throughout the body.

Two primary neuroendocrine pathways are activated during the stress response.³⁸ The first is the Hypothalamic-Pituitary-Adrenal (HPA) axis, culminating in the release of glucocorticoid (GC) hormones, primarily cortisol in humans, from the adrenal cortex. The second is the Sympathetic Nervous System (SNS), which includes direct neural innervation of lymphoid organs and activation of the Sympathetic-Adreno-Medullar (SAM) axis, leading to the release of catecholamine (CA) neurotransmitters/hormones, namely norepinephrine (NE; noradrenaline) and epinephrine (Epi; adrenaline). These stress mediators – GCs and CAs – circulate throughout the body and bind to specific receptors expressed on various immune cells, including NK cells, thereby modulating their function, distribution, trafficking, and overall activity.³⁸

C. Report Focus and Scope

Early research in PNI, dating back several decades, established that psychological stress can significantly alter immune parameters in humans.⁴⁰ Among the various immune cell types, NK cells have frequently been reported as being particularly responsive, often showing suppressed activity under conditions of chronic stress.⁴⁰ Given the critical role of NK cells in controlling malignancies ⁸, this observation has spurred considerable interest in the potential links between stress, NK cell function, and cancer.

This report aims to synthesize the peer-reviewed scientific literature published from 1980 onwards to address two central questions:

1. What are the potential biological mechanisms underlying the apparent heightened sensitivity of NK cells to the immunomodulatory effects of psychological stress, particularly suppression?
2. What are the implications of stress-induced alterations in NK cell function for cancer initiation, progression, and metastasis?

The analysis will draw exclusively upon the provided research materials, focusing on studies investigating the direct effects of stress mediators on NK cells and the documented associations between stress, NK cell activity, and cancer-related outcomes in both human and animal models. In accordance with the specified guidelines, this report will strictly avoid any discussion of therapeutic interventions or treatment suggestions.

II. The Neurobiology of the Stress Response

The physiological response to stress involves a complex interplay between the nervous and endocrine systems, primarily mediated by the HPA axis and the SNS/SAM axis. These systems orchestrate adaptive changes aimed at coping with perceived threats, but their chronic activation can lead to detrimental health consequences.

A. The Hypothalamic-Pituitary-Adrenal (HPA) Axis

The HPA axis represents the primary neuroendocrine pathway governing the release of glucocorticoids.⁵¹ Upon perception of a stressor, neurons in the paraventricular nucleus (PVN) of the hypothalamus release corticotropin-releasing hormone (CRH).⁴¹ CRH travels through the hypophyseal portal system to the anterior pituitary gland, stimulating the secretion of adrenocorticotropic hormone (ACTH).⁴¹ ACTH then enters the systemic circulation and acts on the adrenal cortex, specifically the zona fasciculata and zona reticularis, prompting the synthesis and release of glucocorticoids (cortisol in humans, corticosterone in rodents).⁴¹

Glucocorticoids exert widespread effects on multiple organ systems, playing a crucial role in mobilizing energy resources (e.g., increasing glucose availability) and modulating physiological processes to meet the demands of the stressor.⁵¹ They are essential not only during stress but also for maintaining basal homeostasis.⁵¹ The HPA axis is tightly regulated by negative feedback mechanisms, whereby elevated circulating GC levels inhibit further CRH and ACTH release at the levels of the hypothalamus and pituitary, respectively, thus serving to terminate the stress response once the challenge has subsided.⁴⁵ Rapid feedback mechanisms involving endocannabinoids at the PVN level also contribute to shutting off the HPA axis.⁵¹ Beyond the classical ACTH-GC pathway, stress can also trigger the release of other pituitary hormones with known immunomodulatory effects, such as alpha-melanocyte stimulating hormone (α-MSH), arginine vasopressin (AVP), oxytocin, and prolactin, adding further complexity to the neuroendocrine response.⁷² The specific pattern and magnitude of hormone release can vary depending on the nature of the stressor and the physiological state of the individual.⁷²

B. The Sympathetic Nervous System (SNS) and Sympathetic-Adreno-Medullar (SAM) Axis

The SNS provides a rapid response to stress, often characterized as the “fight-or-flight” reaction.³⁸ Stress signals originating in the brain activate sympathetic preganglionic neurons in the spinal cord. These neurons synapse with postganglionic neurons in sympathetic ganglia or directly innervate the adrenal medulla.⁴¹

Postganglionic sympathetic nerve fibers release the neurotransmitter norepinephrine (NE) directly onto target tissues, including primary and secondary lymphoid organs like the bone marrow, thymus, spleen, and lymph nodes.⁴⁰ This direct innervation allows for localized neural control of immune cell function within these tissues. Simultaneously, activation of the adrenal medulla (the SAM axis component) triggers the release of both epinephrine (Epi) and norepinephrine (NE) as hormones into the bloodstream.⁴⁰ These circulating catecholamines act systemically on various organs, including immune cells expressing adrenergic receptors (ARs). Once the stressor is removed, the parasympathetic nervous system typically becomes dominant, promoting recovery and restoring basal physiological functions.⁴¹

C. Acute vs. Chronic Stress: Differential Neuroendocrine and Immune Effects

The duration and nature of the stressor significantly influence the resulting neuroendocrine and immune responses.⁴⁰ Acute stress, typically lasting minutes to hours (e.g., public speaking, academic examinations), triggers a transient activation of the HPA and SNS/SAM axes.⁴⁰ This acute response can lead to temporary, potentially adaptive changes in the immune system. For instance, acute stressors have been associated with an upregulation or mobilization of certain components of innate immunity, including NK cells.⁴⁰ Rapid release of catecholamines during acute stress can quickly increase the number of circulating NK cells, potentially enhancing immune surveillance during immediate threats.⁶² This initial phase might represent an adaptive evolutionary response, preparing the organism to fight infection or repair wounds that might occur during a “fight-or-flight” situation.⁴⁰

In stark contrast, chronic stress, which persists for days, weeks, months, or even years (e.g., caring for a chronically ill relative, bereavement, persistent work stress, coping with a cancer diagnosis), leads to sustained or repeated activation of the HPA and SNS pathways.⁴¹ This results in prolonged exposure of the body, including the immune system, to elevated levels of glucocorticoids and catecholamines.⁴¹ Chronic stress is generally associated with maladaptive changes in immune function, often characterized by suppression or dysregulation, particularly affecting cellular immunity.⁴⁰ This includes reduced NK cell activity (NKCA), impaired T cell proliferation and function, and shifts in cytokine balance.⁴⁰

The differential impact of acute versus chronic stress highlights the temporal dynamics of the neuroendocrine-immune interaction. While the initial, rapid catecholamine surge during acute stress might temporarily enhance NK cell mobilization and potentially some functions, the sustained elevation of glucocorticoids, alongside chronic catecholamine exposure, during chronic stress appears to drive the more commonly observed immunosuppressive effects, particularly on NK cell cytotoxic function.⁴⁰

Furthermore, the release of GCs and CAs into the systemic circulation provides a crucial mechanism by which psychological stress, perceived and processed within the CNS, can exert widespread influence over immune cells residing in peripheral tissues and lymphoid organs, and potentially even within specialized microenvironments such as tumors.³⁸ This systemic hormonal signaling forms the physiological basis for the observed links between psychological states and peripheral immune function.

III. Functional Consequences of Stress Mediator Exposure on NK Cells

Exposure to glucocorticoids and catecholamines, the primary mediators of the stress response, elicits a range of effects on NK cell biology, influencing their cytotoxic capacity, cytokine secretion profiles, proliferation, survival, and trafficking patterns. These effects are often complex and depend heavily on the specific context, including the duration and concentration of hormone exposure and the presence of other activating signals.

A. Glucocorticoid (GC) Effects on NK Cells

Glucocorticoids exert profound and multifaceted effects on NK cells, primarily mediated through the intracellular Glucocorticoid Receptor (GR).⁷⁸

• Cytotoxicity (NKCA): A consistent finding across numerous studies is the suppression of NK cell cytotoxic activity by GCs.⁶⁶ Treatment with synthetic GCs like dexamethasone or methylprednisolone significantly reduces the ability of NK cells to lyse standard tumor target cells in vitro. This suppression appears multi-faceted, involving a reduction in the production and/or storage of key cytotoxic effector molecules, namely perforin and granzyme B, within the NK cell granules.⁶⁶ Additionally, GCs can impair the initial binding of NK cells to their targets, partly through reduced surface expression of adhesion molecules like Lymphocyte Function-associated Antigen-1 (LFA-1).⁶⁶ Mechanistically, this suppression involves GR-mediated epigenetic modifications. Upon activation by GCs, the GR translocates to the nucleus and recruits corepressor molecules and histone deacetylases (HDACs) to the promoter regions of genes encoding perforin (PFP) and granzyme B (GZMB). This leads to decreased histone acetylation at these promoters, reducing chromatin accessibility and ultimately suppressing the transcription of these critical cytotoxic genes.⁶⁶
• Cytokine Production: The effects of GCs on NK cell cytokine production are more complex and can appear dichotomous. On one hand, GCs can suppress the constitutive and stimulated production of key pro-inflammatory and immunoregulatory cytokines such as IFN-γ and TNF-α.⁶⁶ This aligns with the general anti-inflammatory role of GCs. However, under certain conditions, GCs can paradoxically prime or prepare NK cells for enhanced cytokine production upon subsequent activation.⁸¹ Studies have shown that pre-treatment with GCs can lead to increased IFN-γ and IL-6 secretion when NK cells are later stimulated, particularly in the presence of synergistic cytokines like IL-2 and IL-12.⁸¹ This priming effect also appears to involve epigenetic mechanisms, specifically an increase in histone acetylation and chromatin accessibility at the regulatory regions of the IFNG and IL6 genes, making them more readily transcribed upon subsequent stimulation.⁸¹
• Proliferation and Survival: GC effects on NK cell proliferation and survival are also context-dependent. Some studies report that GC signaling, via the GR-associated protein GITR, can suppress IL-15-driven NK cell proliferation and increase apoptosis.⁸⁴ This pro-apoptotic effect might involve the mitochondrial pathway, as suggested by diminished expression of the anti-apoptotic protein Bcl-XL and the pro-apoptotic protein phospho-Bad.⁸⁴ Conversely, other studies demonstrate that GCs (specifically dexamethasone) can significantly enhance the proliferation and survival of primary human NK cells when they are co-stimulated with the cytokines IL-2 and IL-12.⁸³ This pro-survival effect under specific cytokine conditions might be linked to improved mitochondrial function.⁸³
• Receptor Expression: GCs can modulate the expression of various receptors on the NK cell surface. Treatment with methylprednisolone has been shown to reduce the surface expression of key activating receptors, including NKp46 and NKp30, as well as the IL-2-inducible activating receptor NKp44.⁷⁹ Furthermore, GCs can induce the expression of the inhibitory immune checkpoint receptor Programmed Death-1 (PD-1) on spleen NK cells, potentially contributing to immune suppression.⁸⁶ They can also upregulate the Glucocorticoid-Induced TNFR-Related protein (GITR), although subsequent engagement of GITR itself appears to negatively regulate NK cell activation.⁸⁴
• Dose and Time Dependency: It is important to note that the effects of GCs are often dependent on concentration and duration of exposure. Lower concentrations or shorter exposure times may exert modulating or even enhancing effects on certain immune parameters, whereas the profound immunosuppressive effects, particularly on cytotoxicity, are more typically observed at higher concentrations and with prolonged exposure, conditions often associated with chronic stress or therapeutic administration.⁸²

Table 1: Summary of Glucocorticoid Effects on Human and Animal NK Cell Functions (1980-Present)

(Note: ↓ indicates decrease/suppression; ↑ indicates increase/enhancement. Effects are primarily mediated via the Glucocorticoid Receptor (GR).)

B. Catecholamine (CA) Effects on NK Cells

Catecholamines, acting primarily through adrenergic receptors (ARs) on NK cells, also exert significant immunomodulatory effects, particularly influencing cell trafficking and certain effector functions.

• Cytotoxicity (NKCA): In vitro studies often report that catecholamines, such as norepinephrine, suppress NK cell cytotoxicity against target cells.⁸⁷ This suppression appears to be mediated mainly through β-adrenergic receptors, specifically the β2-AR subtype.⁷⁶ Epinephrine has been shown to inhibit NK cell degranulation, a key step in cytotoxic granule release.⁷⁶ However, in vivo administration of catecholamines (both Epi and NE) typically leads to a rapid and significant increase in NKCA measured in peripheral blood.⁶³ This apparent contradiction is largely explained by the potent effect of CAs on NK cell trafficking; the increased blood NKCA likely reflects a surge in the number of NK cells mobilized into the circulation, rather than an enhancement of the cytotoxic capacity of individual cells.⁴⁰ Studies controlling for cell number often show inhibition or no change in per-cell lytic activity.
• Trafficking and Mobilization: Perhaps the most dramatic and consistent effect of catecholamines, particularly epinephrine, on NK cells is the rapid mobilization of these cells into the peripheral circulation.⁶² Intravenous infusion of Epi or NE in humans causes a marked increase (up to 600% with Epi) in the number of circulating NK cells (CD16⁺ or CD56⁺⁾ within minutes.⁶² This effect is transient, with cell numbers returning towards baseline within one to two hours post-infusion.⁶³ This mobilization is mediated predominantly via β2-ARs, as it can be blocked by non-selective β-blockers (like propranolol) but not by β1-selective blockers.⁶² Importantly, this effect is independent of the spleen, suggesting recruitment from other marginal pools, likely the vascular endothelium or potentially the lungs.⁶² A proposed mechanism involves CA-induced, β2-AR-mediated reduction in the binding activity of the integrin LFA-1 on NK cells, facilitating their detachment from endothelial cells and entry into the circulation.⁷⁶ This rapid redistribution suggests a primary role for CAs in regulating NK cell location and availability during acute stress.
• Cytokine Production: Catecholamines generally exert a suppressive effect on the production of Type 1 pro-inflammatory cytokines by immune cells. Acting via the β2-AR–cAMP–PKA pathway, CAs like NE and Epi inhibit the production of IFN-γ by NK cells and other lymphocytes.⁵² They also suppress the production of IL-12 by antigen-presenting cells (APCs), which indirectly dampens NK cell activation and IFN-γ release, as IL-12 is a potent NK cell activator.⁵² Norepinephrine has also been shown to reduce Concanavalin A-induced IL-2 production by rat splenocytes, an effect blocked by both α- and β-antagonists.⁸⁷ However, effects on TNF-α production by NK cells may be minimal in some contexts.⁶¹ This pattern suggests that CAs may promote a shift away from cellular (Th1-type) immunity towards humoral (Th2-type) immunity.⁵²
• Proliferation and Activation: The effects of CAs on NK cell proliferation and activation appear complex. Suppression of IL-2 production ⁸⁷ could indirectly hinder proliferation, which often depends on IL-2 or IL-15 signaling.³ However, studies using repeated social disruption (SDR) stress models in mice, which involve sympathetic activation, have reported an increase in NK cell activation markers (CD16, CD69) and enhanced functional potential (cytolytic activity, IFN-γ production upon restimulation) in splenic and lung NK cells.⁸⁸ These “priming” effects were blocked by the β-blocker propranolol, indicating mediation via β-AR signaling.⁸⁸ Furthermore, elegant studies using mice with NK cell-specific deletion of the β2-AR (Adrb2) demonstrated that cell-intrinsic β2-AR signaling is essential for optimal NK cell clonal expansion, proliferation, and memory formation during mouse cytomegalovirus (MCMV) infection.⁸⁹ This suggests that while acute high-dose CA exposure might inhibit some functions, basal or infection-induced adrenergic signaling via β2-AR is actually required for robust adaptive NK cell responses in certain contexts.
• Receptor Expression: Catecholamine signaling can influence the expression of receptors on NK cells. The SDR stress model showed increased CD16 and CD69, and reduced inhibitory receptors NKG2A and Ly49A, consistent with an activated phenotype.⁸⁸ Conversely, chronic stress associated with sleep deprivation, which elevates both CAs and GCs, led to reduced NK cell numbers and function, accompanied by an increase in β2-AR expression on NK cells. This upregulation of β2-AR was potentially driven by the elevated GCs, suggesting a mechanism by which chronic stress might sensitize NK cells to the inhibitory effects of catecholamines.⁹⁰ During viral infection (MCMV), NK cells were found to upregulate Adrb2 expression in an IL-12/STAT4-dependent manner, highlighting a dynamic regulation of adrenergic sensitivity during immune responses.⁸⁹

Table 2: Summary of Catecholamine Effects on Human and Animal NK Cell Functions (1980-Present)

(Note: ↓ indicates decrease/suppression; ↑ indicates increase/enhancement. Effects are primarily mediated via β2-Adrenergic Receptors (β2-AR), though α-AR involvement is noted for IL-2. CA = Catecholamines (Epinephrine/Adrenaline, Norepinephrine/Noradrenaline).)

C. Context Dependency and Interactions

The biological impact of stress hormones on NK cells is clearly not uniform but is highly dependent on a multitude of factors.⁷⁵ The specific hormone (GCs vs. CAs), its concentration, and the duration of exposure (acute vs. chronic) are primary determinants.⁸² Furthermore, the specific NK cell function being assessed (e.g., cytotoxicity, cytokine secretion, proliferation, trafficking) can show differential sensitivity.⁶³ Different NK cell subsets (e.g., CD56^bright vs. CD56^dim) may also respond differently, although this is less explored in the context of direct stress hormone effects in the provided literature.

Crucially, the surrounding cytokine milieu dramatically influences how NK cells respond to stress hormones.³ For instance, the ability of GCs to enhance NK cell proliferation and survival is critically dependent on the simultaneous presence of activating cytokines like IL-2 and IL-12.⁸³ Similarly, the requirement for β2-AR signaling for optimal NK cell expansion during viral infection occurs in the context of IL-12 signaling needed for receptor upregulation.⁸⁹ This implies that during inflammatory conditions or infections, where cytokines are abundant, the net effect of stress hormones might differ significantly from their effects on resting NK cells. The interplay between stress hormone signals and cytokine signals determines the ultimate functional outcome.

This complexity underscores that describing stress effects as simple “immunosuppression” is often an oversimplification. Both GCs and CAs exhibit dichotomous actions. GCs strongly suppress cytotoxicity but can simultaneously prime NK cells for enhanced pro-inflammatory cytokine release upon subsequent stimulation.⁸¹ Catecholamines suppress per-cell cytotoxicity and IFN-γ production in vitro but cause a dramatic increase in the number of circulating NK cells in vivo.⁶³ Therefore, stress hormones act as multifaceted modulators of NK cell function, rather than purely suppressive agents, with the final outcome depending heavily on the specific biological context and the parameters measured.

IV. Potential Mechanisms for Heightened NK Cell Sensitivity to Stress

The observation that NK cells are particularly responsive to stress-induced modulation, especially suppression of cytotoxic function under chronic stress, likely stems from their specific expression patterns of stress hormone receptors and the downstream signaling pathways engaged by these receptors.

A. Glucocorticoid Receptor (GR) Expression and Signaling in NK Cells

NK cells, like many other immune cells, express functional Glucocorticoid Receptors (GRs, specifically NR3C1), which are the primary mediators of GC effects.⁵³ Upon binding GCs (e.g., cortisol or synthetic analogs like dexamethasone), the GR undergoes conformational changes, dissociates from chaperone proteins, and translocates from the cytoplasm to the nucleus.⁷⁸

Once in the nucleus, the activated GR can regulate gene expression through several mechanisms. For the suppression of NK cell effector functions, a key mechanism involves GR-mediated transrepression via epigenetic modifications.⁶⁶ Studies using the NK92 cell line and primary NK cells have shown that GC treatment leads to the recruitment of the GR, along with corepressor molecules like Silencing Mediator for Retinoid and Thyroid-hormone receptors (SMRT), and Class I histone deacetylases, specifically HDAC1, to the promoter regions of critical NK effector genes, including those encoding perforin (PFP) and granzyme B (GZMB).⁷⁸ This recruitment results in the removal of acetyl groups from histone tails (histone deacetylation) at these specific gene loci.⁶⁶ Reduced histone acetylation leads to chromatin condensation, making the DNA less accessible to the transcriptional machinery, thereby decreasing the transcription of these genes and ultimately reducing the levels of perforin and granzyme B protein.⁶⁶ This epigenetic silencing provides a direct mechanism for the observed GC-induced suppression of NKCA.

Conversely, the GR can also mediate gene activation, contributing to the priming effects observed for cytokine production. GC treatment has been shown to increase histone acetylation and chromatin accessibility at regulatory regions for genes like IFNG (IFN-γ) and IL6 (IL-6).⁸¹ This suggests that GR can recruit coactivators and histone acetyltransferases (HATs) to certain gene loci, making them poised for enhanced transcription upon subsequent stimulation.

Beyond epigenetic regulation, GR signaling can also interfere with other intracellular pathways. For example, GR activation (potentially via GITR upregulation and subsequent signaling) has been shown to block the phosphorylation and activation of key signaling molecules involved in proliferation and survival pathways, such as Signal Transducer and Activator of Transcription 5 (STAT5) and Protein Kinase B (Akt).⁸⁴ The ability of GCs to induce sustained changes in NK cell potential via epigenetic modifications, affecting the very core of their cytotoxic machinery, represents a powerful mechanism through which chronic stress, characterized by prolonged GC exposure, could lead to durable impairments in NK cell function.⁴⁹

B. Adrenergic Receptor (AR) Expression and Signaling in NK Cells

NK cells express adrenergic receptors (ARs), enabling them to respond directly to catecholamines released from sympathetic nerve endings and the adrenal medulla.⁴⁰ While both α- and β-ARs are found on various immune cells, NK cells are consistently reported to express particularly high levels of the β2-adrenergic receptor (β2-AR) compared to other lymphocyte populations, such as T cells.⁴⁰ Some studies also suggest a role for α-ARs in mediating certain CA effects on lymphocytes, such as IL-2 production.⁸⁷

The β2-AR is considered the predominant subtype mediating the effects of catecholamines (especially epinephrine) on NK cells.⁶² The β2-AR is a G protein-coupled receptor (GPCR), typically linked to the stimulatory G protein, Gs.⁵⁴ Upon ligand binding (Epi or NE), the receptor activates adenylyl cyclase, leading to an increase in intracellular cyclic adenosine monophosphate (cAMP) levels. Elevated cAMP then activates Protein Kinase A (PKA).⁵²

This canonical β2-AR–cAMP–PKA signaling pathway is implicated in many of the observed effects of CAs on NK cells. It mediates the suppression of IFN-γ production ⁵² and inhibits cytotoxic functions like degranulation ⁷⁶ and target cell lysis.⁷⁶ Mechanistically, PKA activation can interfere with early intracellular signaling events triggered by NK cell activating receptors, such as the phosphorylation of signaling adaptors (e.g., 2B4), downstream kinases (e.g., ERK), and effector molecules (e.g., Vav).⁷⁶ This pathway is also responsible for the rapid modulation of LFA-1 integrin activity, which underlies the CA-induced mobilization of NK cells from marginal pools into the circulation.⁷⁶

However, β2-AR signaling in NK cells is not solely inhibitory. As mentioned previously, cell-intrinsic β2-AR signaling is required for the optimal expansion and memory development of NK cells during MCMV infection in mice.⁸⁹ This proliferative response was dependent on prior IL-12/STAT4 signaling, which upregulated β2-AR expression on the NK cells, highlighting crosstalk between cytokine and adrenergic pathways.⁸⁹ This suggests that the role of β2-AR signaling can shift from inhibitory (for acute effector functions) to potentially supportive (for proliferation/expansion during specific immune responses) depending on the context and duration of signaling.

C. Comparative Receptor Expression and Sensitivity

The differential expression of stress hormone receptors on various immune cell populations likely plays a significant role in determining their relative sensitivity to neuroendocrine modulation. The notably high density and/or affinity of β2-ARs on NK cells compared to T cells ⁴⁰ provides a compelling molecular explanation for the pronounced and rapid effects of catecholamines on NK cell trafficking and function.⁶² This high receptor density means NK cells are poised to respond swiftly and strongly to surges in epinephrine and norepinephrine during acute stress, leading to their rapid mobilization from endothelial margins into the circulation. While T cells also express β2-ARs and are affected by CAs, the lower receptor density may result in less dramatic or slower responses compared to NK cells.⁴⁰

Regarding glucocorticoid sensitivity, while GRs are expressed broadly across immune cells ⁵³, the specific downstream consequences of GR activation might differ between cell types. The well-documented ability of GR signaling in NK cells to directly target and epigenetically suppress the core cytotoxic machinery genes (PFP, GZMB) through HDAC recruitment offers a potent mechanism for inhibiting their primary effector function.⁶⁶ Whether this specific epigenetic pathway is engaged to the same extent or has the same functional impact in other cytotoxic cells like CD8+ T cells requires further comparative investigation, but it could contribute to the perceived sensitivity of NK cell cytotoxicity to GC-mediated suppression.

Therefore, the heightened sensitivity of NK cells to psychological stress likely arises from a combination of factors: high expression of β2-ARs rendering them highly responsive to catecholamines (especially for trafficking), and potent GR-mediated epigenetic suppression of their cytotoxic machinery contributing to their vulnerability to glucocorticoid effects, particularly under chronic stress conditions.

Table 3: Expression of Stress Hormone Receptors on NK Cells Compared to Other Leukocytes

(Note: Relative expression levels are based on comparative statements within the provided snippets. ↓ indicates decrease/suppression; ↑ indicates increase/enhancement. ↑↑ indicates a particularly strong effect.)

V. Implications for Cancer: The Stress-NK Cell Axis

The sensitivity of NK cells to stress-induced modulation carries significant potential implications for cancer biology, given their fundamental role in the immune system’s defense against malignancy. Understanding this axis is crucial for comprehending how psychological factors might influence cancer risk and progression.

A. The Critical Role of NK Cells in Anti-Tumor Immunity

NK cells are central players in the innate immune response to cancer.³ Their importance stems from several key functions:

1. Direct Cytotoxicity: NK cells can directly recognize and kill tumor cells, particularly those that have downregulated MHC class I molecules to evade detection by cytotoxic T lymphocytes (CTLs).² They achieve this through the release of cytotoxic granules containing perforin and granzymes, inducing apoptosis in the target cell.⁷
2. Antibody-Dependent Cellular Cytotoxicity (ADCC): NK cells express the Fc receptor CD16, allowing them to bind to antibody-coated tumor cells and mediate ADCC, a crucial mechanism for some cancer immunotherapies.⁷
3. Cytokine Production: Upon activation, NK cells rapidly secrete cytokines like IFN-γ and TNF-α.³ IFN-γ, in particular, plays a vital role in activating macrophages, enhancing antigen presentation by dendritic cells (DCs), and promoting the development of adaptive Th1 and CTL responses against the tumor.¹¹
4. Immune Cell Crosstalk: NK cells interact with other immune cells, notably DCs. They can promote DC maturation, while DCs, in turn, can activate NK cells (e.g., via IL-12, IL-15 trans-presentation), thus amplifying the overall anti-tumor immune response.³

Natural killer cells (yellow) identifies and kills cancer cells (pink) or virus infected cells. (Photo: eye of science).

Collectively, these functions position NK cells as critical effectors in “immune surveillance” – the process by which the immune system recognizes and eliminates nascent transformed cells before they develop into clinically detectable tumors.¹ Furthermore, NK cells are thought to be particularly important in controlling tumor metastasis, the process by which cancer spreads to distant organs, which is the primary cause of cancer-related mortality.¹¹ They can target and eliminate circulating tumor cells (CTCs) in the bloodstream and attack micrometastases attempting to establish in secondary sites.²¹

B. Evidence Linking Psychological Stress, NK Cell Function, and Cancer Outcomes

A substantial body of research, spanning decades, has explored the connections between psychological factors, NK cell activity, and cancer-related outcomes.

• Human Studies: Numerous observational studies in humans have linked experiences of psychological stress (including adverse life events, perceived stress, chronic stress), depression, anxiety, and lack of social support with reduced peripheral blood NK cell activity (NKCA).⁴⁰ For example, reduced NKCA has been documented in individuals undergoing the stress of a breast biopsy, regardless of the diagnosis ⁷⁰, as well as in those experiencing bereavement or the chronic stress of caregiving.⁴⁰ Prospective cohort studies have associated lower baseline NKCA in initially healthy individuals with a significantly increased risk of developing cancer over subsequent years.¹¹ Furthermore, in patients already diagnosed with cancer, lower NKCA or reduced infiltration of NK cells into the tumor tissue has been consistently associated with poorer prognosis, including increased risk of recurrence and metastasis, and decreased overall survival across a wide range of malignancies (e.g., colorectal, breast, prostate, gastric, hepatocellular carcinoma, melanoma, and others).¹² Conversely, higher levels of NK cell infiltration into solid tumors are generally predictive of better survival outcomes.²⁵
  However, the epidemiological picture is not entirely uniform. Some large, well-controlled studies have failed to find an association between major life stressors (such as having a child diagnosed with cancer) and the overall incidence of cancer or mortality from non-malignant diseases in the stressed individuals (parents).¹⁰² This highlights the complexity of the relationship and the potential influence of factors like individual resilience, coping mechanisms, stressor type and duration, and the specific cancer type. Meta-analyses generally support a link between stress-related psychosocial factors and cancer outcomes, particularly progression and mortality, but emphasize the need to consider the chronicity and severity of the stressor.⁴³ The evidence appears stronger for stress influencing cancer progression and metastasis rather than initiation.⁴⁶
• Preclinical Animal Models: Studies in rodent models provide more direct experimental evidence for a causal link. Exposing animals to various chronic stressors (e.g., social disruption, restraint stress) consistently leads to suppression of NK cell activity and promotes accelerated tumor growth and increased metastatic spread.⁴⁶ These effects are mediated by the stress-induced release of catecholamines and glucocorticoids, acting on their respective receptors on immune and potentially tumor cells.⁴⁶ Pharmacological blockade of β-adrenergic receptors (using β-blockers) can partially reverse the tumor-promoting effects of stress in some models, further implicating the SNS pathway.⁹³ Animal studies have particularly highlighted the detrimental impact of stress-induced NK cell suppression during the peri-surgical period, a time known to be vulnerable for metastatic seeding.⁶⁹

C. Stress Hormones, NK Cells, and the Tumor Microenvironment (TME)

The tumor microenvironment (TME) is the complex ecosystem surrounding a tumor, comprising cancer cells, stromal cells (like fibroblasts and endothelial cells), extracellular matrix components, and various infiltrating immune cells.¹⁰³ The TME plays a critical role in cancer progression and response to therapy. Often, the TME becomes immunosuppressive, actively hindering the function of anti-tumor immune cells like NK cells and CTLs.⁵ This suppression can be mediated by various factors within the TME, including the accumulation of immunosuppressive cell populations (e.g., regulatory T cells (Tregs), myeloid-derived suppressor cells (MDSCs), M2-polarized macrophages), the secretion of immunosuppressive cytokines (e.g., TGF-β, IL-10), metabolic alterations (such as hypoxia and nutrient depletion), and the expression of inhibitory ligands (e.g., PD-L1, HLA-E) on tumor and stromal cells.⁹⁶

Emerging evidence strongly suggests that chronic psychological stress actively contributes to shaping a pro-tumorigenic and immunosuppressive TME.⁴⁶ Stress hormones, namely glucocorticoids and catecholamines, released systemically due to HPA and SNS activation, can infiltrate the TME and exert direct effects on its various components.⁴⁶ They can act on cancer cells themselves, promoting processes like survival, proliferation, invasion, and angiogenesis.⁴⁶ They also influence stromal cells, potentially promoting fibrosis or altering vascular function.⁵⁸

Crucially, stress hormones act directly on immune cells within the TME, including NK cells. By binding to GRs and ARs expressed on tumor-infiltrating NK cells, GCs and CAs can suppress their cytotoxic function and cytokine production locally within the tumor niche, using the same mechanisms described earlier (e.g., epigenetic silencing of perforin/granzyme B by GCs, β2-AR-mediated inhibition of activation signals by CAs).⁴⁶ Stress can also induce the expression of inhibitory checkpoint receptors like PD-1 on NK cells, further contributing to their inactivation within the TME.⁸⁶

Furthermore, chronic stress can promote a state of chronic low-grade systemic inflammation.⁴² While seemingly counterintuitive, this unresolved inflammation can paradoxically fuel tumor growth, promote angiogenesis, and create a TME that is hostile to the function of effector lymphocytes like NK cells, while potentially supporting immunosuppressive cell populations.⁴⁷ Therefore, psychological stress impacts cancer not only through systemic immune modulation but also by directly altering the local conditions within the TME, creating a microenvironment that favors tumor escape from NK cell control.

The particular importance of NK cells in controlling metastasis ¹¹, combined with the inherent stresses faced by cancer cells during the metastatic cascade (detachment, survival in circulation, extravasation, colonization of a new environment) ²¹, suggests a specific vulnerability. If the primary immune defense against disseminating tumor cells – the NK cell system – is compromised by chronic stress, then the likelihood of successful metastatic seeding and outgrowth may be significantly increased. This provides a strong mechanistic rationale for why chronic stress appears to be more robustly linked to cancer progression and metastasis than to the initial development of primary tumors in many studies.⁴⁶

VI. Synthesis and Conclusion

A. Summary of Mechanisms Underlying NK Cell Stress Sensitivity

The available peer-reviewed evidence accumulated since 1980 indicates that Natural Killer cells exhibit a notable sensitivity to modulation by psychological stress, mediated primarily by the neuroendocrine hormones glucocorticoids (GCs) and catecholamines (CAs). Several key mechanisms contribute to this sensitivity:

• Receptor Expression: NK cells express functional receptors for both GCs (Glucocorticoid Receptor, GR) and CAs (predominantly the β2-Adrenergic Receptor, β2-AR). Notably, the density and/or affinity of β2-ARs appear to be particularly high on NK cells compared to some other lymphocyte populations, such as T cells.⁴⁰
• Direct Signaling Pathways:
  • Glucocorticoids: GR activation leads to potent suppression of NK cell cytotoxicity, largely through epigenetic mechanisms involving the recruitment of corepressors and histone deacetylases (HDAC1) to the promoters of key effector genes like PFP (perforin) and GZMB (granzyme B), resulting in reduced histone acetylation and gene silencing.⁶⁶ GR signaling can also modulate cytokine gene expression (suppressing or priming depending on the gene and context) and interfere with proliferation/survival pathways (e.g., STAT5, Akt).⁸¹
  • Catecholamines: β2-AR activation, typically via the cAMP-PKA pathway, inhibits early NK cell activation signals, suppresses IFN-γ production, and reduces degranulation and per-cell cytotoxicity.⁵² This pathway also rapidly modulates integrin activity (LFA-1), facilitating NK cell detachment and mobilization.⁷⁶ Cell-intrinsic β2-AR signaling is also implicated in regulating NK cell expansion in specific contexts like viral infection.⁸⁹
• Functional Consequences: These signaling events translate into distinct functional outcomes. CAs induce rapid and pronounced changes in NK cell trafficking, mobilizing them into the circulation.⁶² Both GCs and CAs generally suppress NK cell cytotoxic function on a per-cell basis, particularly under chronic exposure conditions.⁶⁶ Cytokine production is complexly modulated, with general suppression of IFN-γ by CAs, and both suppression and priming effects observed with GCs depending on context and co-stimulation.⁶⁶ Effects on proliferation and survival are also highly context-dependent, influenced by the specific stress hormone and the presence of activating cytokines like IL-2, IL-12, or IL-15.⁸³

B. Consolidated View: Impact of Stress-Induced NK Cell Changes on Cancer

Synthesizing the evidence, a plausible biological pathway emerges linking chronic psychological stress to adverse cancer outcomes via modulation of NK cell function. Chronic stress leads to sustained activation of the HPA axis and SNS, resulting in prolonged exposure to elevated levels of GCs and CAs.⁴⁹ These hormones act systemically and also penetrate the tumor microenvironment (TME).⁴⁶

Within this context, stress hormones directly suppress critical anti-tumor functions of NK cells, most notably their cytotoxic capacity required to eliminate tumor cells, and can alter their cytokine profile (e.g., reducing IFN-γ needed for broader immune activation).⁶⁷ Simultaneously, stress hormones contribute to creating an overall immunosuppressive TME by acting on tumor cells, stromal cells, and other immune cell populations.⁴⁶

The functional impairment of NK cells under chronic stress has significant implications for cancer control. It likely compromises the effectiveness of immune surveillance against newly arising transformed cells. Perhaps more critically, given the key role of NK cells in combating metastasis, stress-induced NK cell suppression may significantly impair the body’s ability to eliminate disseminating tumor cells and prevent the formation of secondary tumors.¹¹ This aligns with observations from numerous preclinical models and many, though not all, human correlational studies suggesting that chronic stress is associated with accelerated cancer progression, increased metastasis, and poorer survival.¹¹

It is essential, however, to acknowledge the complexity of these interactions. The impact of stress is influenced by numerous factors, including the type, duration, and intensity of the stressor, individual psychological and biological variability (including coping mechanisms and genetic predispositions), the specific type and stage of cancer, and the interplay with other lifestyle factors and treatments. Furthermore, the potential for acute stress to have different, possibly even transiently beneficial, effects on NK cell mobilization adds another layer of complexity.⁴⁰

C. Concluding Remarks

Based on an extensive review of peer-reviewed literature published from 1980 onwards, Natural Killer cells emerge as a lymphocyte population particularly sensitive to neuroendocrine modulation by psychological stress. This sensitivity appears rooted in their distinct expression profile of receptors for glucocorticoids (GR) and catecholamines (notably high β2-AR levels), coupled with specific downstream signaling pathways, including potent GR-mediated epigenetic regulation of their core cytotoxic machinery.

Chronic psychological stress, through sustained activation of the HPA and SNS axes, leads to prolonged exposure to stress hormones. This exposure results in the suppression of key NK cell anti-tumor functions, particularly cytotoxicity, and contributes to the development of an immunosuppressive tumor microenvironment. Consequently, substantial evidence supports a biologically plausible link between chronic stress, impaired NK cell activity, and potentially adverse cancer outcomes, with implications predominantly for cancer progression and metastatic spread rather than necessarily initiation. While the precise contribution of stress-induced NK cell dysfunction to human cancer burden requires continued investigation, the existing data strongly suggest it is a significant factor in the complex interplay between the mind, the neuroendocrine system, immunity, and malignancy.

References

1. On the Way to Become a Natural Killer Cell – PubMed
2. Five decades of natural killer cell discovery – PMC
3. Use of allogeneic NK cells for cancer immunotherapy – PMC
4. From the “missing self” hypothesis to adaptive NK cells: Insights of NK cell-mediated effector functions in immune surveillance – PubMed
5. NK cells in the tumor microenvironment and thioredoxin activity – JCI
6. The Role of Natural Killer Cells in Autoimmune Diseases – Frontiers
7. Natural killer cell – Wikipedia
8. Natural Killer Activity: Early Days, Advances, and Seminal Observations – PMC
9. Natural Killer Cells Unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy – PMC
10. Human NK cells: surface receptors, inhibitory checkpoints, and translational applications – PMC
11. Natural killer cells: role in local tumor growth and metastasis – PMC
12. A systematic scoping review on natural killer cell function in colorectal cancer – PMC
13. Uterine natural killer cells and successful pregnancy: from mouse experiments to human physiology – Open Exploration Publishing
14. Immune Surveillance of Unhealthy Cells by Natural Killer cells – PMC
15. Natural killer cell-mediated immune surveillance in cancer: Role of tumor microenvironment – PubMed
16. The role of natural killer cells in immune surveillance of cancer – PubMed
17. Natural Killer Cells: Tumor Surveillance and Signaling – PubMed
18. Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells – PubMed
19. Natural killer cell-mediated immunosurveillance of human cancer – PubMed
20. A systematic scoping review on natural killer cell function in colorectal cancer – PubMed
21. The changing role of natural killer cells in cancer metastasis – JCI
22. Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders – PMC
23. Natural killer cell homing and trafficking in tissues and tumors: from biology to application – PMC
24. Immunosurveillance of Cancer and Viral Infections with Regard to Alterations of Human NK Cells Originating from Lifestyle and Aging – MDPI
25. The NK cell-cancer cycle – advances and new challenges in NK cell-based immunotherapies – PMC
26. The changing role of natural killer cells in cancer metastasis – PMC
27. The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy – PMC
28. Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors – Frontiers
29. Does Natural Killer Cell Deficiency (NKD) Increase the Risk of Cancer? NKD May Increase the Risk of Some Virus Induced Cancer – PMC
30. The Prognostic Value of Natural Killer Cells and Their Receptors/Ligands in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis – PMC
31. Prognostic Significance of Tumor-Infiltrating Natural Killer Cells in Solid Tumors: A Systematic Review and Meta-Analysis – PMC
32. Aging of the Immune System: Focus on Natural Killer Cells Phenotype and Functions – PMC
33. The Role of Natural Killer Cells in Autoimmune Diseases – PMC
34. The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy – PMC
35. Activating and inhibitory receptors of natural killer cells – PubMed
36. Current status and future perspective of natural killer cell therapy for cancer – PMC
37. The Abundant NK Cells in Human Secondary Lymphoid Tissues Require Activation to Express Killer Cell Ig-Like Receptors and Become Cytolytic1 – AAI Journals
38. Psychological Stress and the Cutaneous Immune Response: Roles of the HPA Axis and the Sympathetic Nervous System in Atopic Dermatitis and Psoriasis – PubMed Central
39. Psychological Stress and the Cutaneous Immune Response: Roles of the HPA Axis and the Sympathetic Nervous System in Atopic Dermatitis and Psoriasis – PubMed
40. Psychological Stress and the Human Immune System: A Meta-Analytic Study of 30 Years of Inquiry – PMC
41. Physiology, Stress Reaction – StatPearls – NCBI Bookshelf
42. Cancer and Cancer-Related Fatigue and the Interrelationships With Depression, Stress, and Inflammation – PMC
43. Psychosocial stress and cancer risk: a narrative review – ResearchGate
44. Immune and Neuroendocrine Mechanisms of Stress Vulnerability and Resilience – PMC
45. Impact of stress, immunity, and signals from endocrine and nervous system on fascia – ImPress
46. Biobehavioral Factors and Cancer Progression: Physiological Pathways and Mechanisms – PMC
47. Interplay between stress and cancer—A focus on inflammation – PMC
48. Stress and cancer: The mechanisms of immune dysregulation and management – PMC
49. Immunology of Stress: A Review Article – PubMed
50. Immunology of Stress: A Review Article – PMC
51. Regulation of the hypothalamic-pituitary-adrenocortical stress response – PMC
52. Effects of Catecholamines on the Immune Response – ResearchGate
53. What Stress Means for the Invulnerable Reaction – International Journal of Medical Research and Health Sciences
54. Stress and catecholamines modulate the bone marrow microenvironment to promote tumorigenesis – Cell Stress
55. Impact of stress on cancer metastasis – PMC
56. Chronic Stress Promotes Cancer Development – PMC
57. A nervous tumor microenvironment: the impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic response – PubMed Central
58. Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments – PMC
59. Psychosocial stress and immunosuppression in cancer: what can we learn from new research? – PMC
60. Control of Leukocyte Trafficking by Stress-Associated Hormones – Frontiers
61. Glucocorticoids and Catecholamines Affect in Vitro Functionality of Porcine Blood Immune Cells – PMC
62. Catecholamines modulate human NK cell circulation and function via spleen-independent beta 2-adrenergic mechanisms – PubMed
63. Catecholamines induce alterations of distribution and activity of human natural killer (NK) cells – PubMed
64. Adrenergic regulation of immune cell function and inflammation – PMC
65. A Biobehavioral Model of Cancer Stress and Disease Course – PMC
66. Glucocorticoid Dysregulation of Natural Killer Cell Function through Epigenetic Modification – PMC
67. Glucocorticoid dysregulation of natural killer cell function through epigenetic modification – PubMed
68. Impact of psychological stressors on natural killer cell function: A comprehensive analysis based on stressor type, duration, intensity, and species – PubMed
69. Biobehavioral Influences on Cancer Progression – PMC
70. Psychoneuroimmunology and cancer: A decade of discovery, paradigm shifts, and methodological innovations – PMC
71. Psychologic stress, reduced NK cell activity, and cytokine dysregulation in women experiencing diagnostic breast biopsy – PMC
72. The neuroimmune response during stress- a physiological perspective – PMC
73. How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions – Oxford Academic
74. Cell-intrinsic adrenergic signaling controls the adaptive NK cell response to viral infection – PMC
75. Regulation of natural killer cell activity by glucocorticoids, serotonin, dopamine, and epinephrine – PMC
76. Chronic stimulation desensitizes β2‐adrenergic receptor responses in natural killer cells – PMC
77. Immunology of Stress: A Review Article – MDPI
78. Glucocorticoid receptor mediated suppression of natural killer cell activity: identification of associated deacetylase and corepressor molecules – PubMed
79. The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity – PubMed
80. Glucocorticoid receptor mediates the effect of progesterone on uterine natural killer cells – PubMed
81. Glucocorticoids regulate natural killer cell function epigenetically – PubMed
82. Glucocorticoids regulate natural killer cell function epigenetically – PMC
83. Distinct Effects of Dexamethasone on Human Natural Killer Cell Responses Dependent on Cytokines – Frontiers
84. Glucocorticoid-induced tumor necrosis factor receptor negatively regulates activation of human primary natural killer (NK) cells by blocking proliferative signals and increasing NK cell apoptosis – PubMed
85. Effect of the simultaneous administration of glucocorticoids and IL-15 on human NK cell phenotype, proliferation and function – PMC
86. Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 expression on NK cells – PMC
87. Effect of catecholamines on IL-2 production and NK cytotoxicity of rats in vitro – PubMed
88. β-Adrenergic receptor mediated increases in activation and function of natural killer cells following repeated social disruption – PubMed
89. Cell-intrinsic adrenergic signaling controls the adaptive NK cell response to viral infection – PubMed
90. Sleep-deprivation reduces NK cell number and function mediated by β-adrenergic signalling – PubMed
91. Role of adrenergic receptor signalling in neuroimmune communication – PMC
92. Adrenergic regulation of innate immunity: a review – PMC
93. Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response – PMC
94. A Jack of All Trades: Impact of Glucocorticoids on Cellular Cross-Talk in Osteoimmunology – Frontiers
95. Effect of Natural Compounds on NK Cell Activation – PMC
96. The Tumor Microenvironment—A Metabolic Obstacle to NK Cells’ Activity – PMC
97. Vitamin D and Exercise Are Major Determinants of Natural Killer Cell Activity, Which Is Age- and Gender-Specific – Frontiers
98. Prognostic value of natural killer cell activity for patients with HER2 + advanced gastric cancer treated with first-line fluoropyrimidine–platinum doublet plus trastuzumab – PMC
99. Natural killer cell biology and therapy in multiple myeloma: challenges and opportunities – PubMed
100. Role of natural killer cells in cancer – PubMed
101. NK cell infiltration is associated with improved overall survival in solid cancers: A systematic review and meta-analysis – PMC
102. Psychological stress, cancer incidence and mortality from non-malignant diseases – PubMed
103. Role of tumor microenvironment in cancer progression and therapeutic strategy – PMC
104. Critical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic Stress – PubMed
105. HPA-Axis and Inflammatory Reactivity to Acute Stress is Related with Basal HPA-Axis Activity – PMC
106. Stress in the metastatic journey – the role of cell communication and clustering in breast cancer progression and treatment resistance – PubMed

Professional AI assistance:

The Artificial Intelligence (AI) product “Gemini Advanced 2.5″ from Google DeepMind was used in “Deep Research” mode to produce this article. Google DeepMind is a subsidiary of Alphabet Inc.

Balevsky Research Services LTD assisted in formulating the prompt to Gemini.

Related stories you may like:

Autonomic Nerves May Contribute to Prostate Cancer Development
Cancer cells ability to evade apoptosis is amplified by stress
Beta-Adrenoceptors and Tumor Development: Novel Concepts and Clinical Implications
Beta Blockers Hold Substantial Potential for Therapeutical Interventions in Cancer
Beta Blockers Improve Survival in Ovarian Cancer Patients
Beta Adrenoreceptor – Src Kinase Signaling As a Trigger for Cancer Metastasis
A Combination of Beta-Adrenergic Antagonist and Cyclooxygenase-2 Inhibitor Improves Survival Rates in Murine Models of Postoperative Metastasis
Stress-Induced β2-Adrenoceptor-Mediated M2 Macrophage Polarization Promoting Tumor Growth in a Mouse Model of Breast Cancer
Stress Upregulates Suppressor Cells in Breast Cancer
Norepinephrine and β3-Adrenoreceptors Drive Melanoma Progression & Aggressiveness
Animal Stress Model Links the Stress-Induced T-helper 2 Shift to Colon Cancer
Stress and Cancer: A Link Through the Chinese Cultural Revolution